April 1, 2021 The German DAX 30 index may lose ground in the near term on the back of the delayed ratification of the EU Recovery Fund and Chancellor Merkel’s ban on AstraZeneca’s Covid-19 vaccine. Previous Post Oil Gains Ahead of OPEC Meeting on Output Policy Next Post In Squeezed Euro Debt Sales, Governments Curb Inflated Hedge Fund Demand